ZIG
HRMY icon

Zuckerman Investment Group’s Harmony Biosciences HRMY Stock Holding History

Zuckerman Investment Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Hold
78,255
– – 0.24% 52
2026
Q1 		$2.19M Buy
78,255
+2,794
+4% +$91.6K 0.21% 56
2025
Q4 		$2.82M Sell
75,461
-47,794
-39% -$1.57M 0.25% 52
2025
Q3 		$3.4M Buy
+123,255
New +$4.25M 0.31% 49

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zuckerman Investment Group's HRMY Position: Q2 2026 in Review

Zuckerman Investment Group held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 78,255 shares worth $2.85M. The position accounts for 0.24% of the portfolio, ranked #52.

Zuckerman Investment Group first reported a position in HRMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.4M in Q3 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Zuckerman Investment Group held 78,255 shares of Harmony Biosciences worth $2.85M as of Q2 2026.
  • Zuckerman Investment Group left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up 0.24% of Zuckerman Investment Group's portfolio in Q2 2026, its #52 holding.
  • Zuckerman Investment Group first reported a position in Harmony Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Zuckerman Investment Group's Harmony Biosciences position peaked at $3.4M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Zuckerman Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.